Commercializing Gene Therapies
Using High-Touch Services to Enhance Patient Outcomes
Epitope Mapping Orients Immune Interventions
Before Launching an Immune Intervention, Get the Lay of the Land
The Scoop: Tissue Engineering Covers Wide Range of Applications
3D Approach Aims to Replace Human Tissue and Organs
Improving CRISPR-Cas9’s Rate of Homology-Directed Repair
Integrated DNA Technologies Suggests Strategies to Boost Efficiency, Avoid Blunt-End Incorporation, and Reduce Toxicity
For full access to this article login to GEN Select now.
Fine-Tuning Cell-Based Assays
- Years of research and untold costs of development are wasted when a drug is withdrawn from the market. Pharmaceutical companies go to great lengths to prevent such loss, carrying out exhaustive studies from the preclinical phase through late-stage clinical trials to identify problems and eliminate them early. ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.